Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Linaclotide, 72μg	59
Overall Study	STARTED	Linaclotide, 145μg	57
Overall Study	STARTED	Linaclotide, 290μg	62
Overall Study	STARTED	Linaclotide, 579μg	63
Overall Study	STARTED	Placebo	69
Overall Study	COMPLETED	Linaclotide, 72μg	54
Overall Study	COMPLETED	Linaclotide, 145μg	51
Overall Study	COMPLETED	Linaclotide, 290μg	58
Overall Study	COMPLETED	Linaclotide, 579μg	51
Overall Study	COMPLETED	Placebo	61
Overall Study	NOT COMPLETED	Linaclotide, 72μg	5
Overall Study	NOT COMPLETED	Linaclotide, 145μg	6
Overall Study	NOT COMPLETED	Linaclotide, 290μg	4
Overall Study	NOT COMPLETED	Linaclotide, 579μg	12
Overall Study	NOT COMPLETED	Placebo	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00402337/flow